Every intervention Outliyr has scored for metabolic health, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for metabolic health; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
80 of 126 evaluated interventions score 3.0+ out of 10 for metabolic health · 24 comparisons
For metabolic-health, Semaglutide reaches 9.0/10 because Moiz 2024 found about 12.1 percentage points greater weight loss than placebo in non-diabetic obesity trials. The metabolic case is broad: weight, glucose, blood pressure, inflammation,…
Read the Semaglutide report →Tirzepatide achieved about 15% mean body-weight reduction in the SURMOUNT-1 trial, a result that underpins its 8.7/10 rating for the metabolic-health use case Jastreboff 2022. Tirzepatide also lowered waist circumference, systolic blood…
Read the Tirzepatide report →Metformin reduces the incidence of type 2 diabetes by about 31% in high-risk adults, according to the Diabetes Prevention Program trial Knowler 2002. Metformin scores 8.5/10 for the metabolic-health use case, reflecting…
Read the Metformin report →Retatrutide earns 8.5/10 for metabolic-health because Jastreboff 2023 is the cleanest verified anchor for this report. The existing rationale points to this narrower claim: Triple agonism targets appetite, glucose control, weight, waist…
Read the Retatrutide report →A 8.0/10 for metabolic-health fits Zone 2 Cardio because Vabishchevich 2026 supports direction more than certainty. The existing rationale points to this narrower claim: Structured exercise reliably improves glycemic control. this verified…
Read the Zone 2 Cardio report →The metabolic health case for Taurine is 8.0/10 because Tzang 2024 reports 25 RCTs and 1024 participants; lower SBP, DBP, fasting blood glucose, and triglycerides; no significant adverse-effect excess. Guan 2020 points…
Read the Taurine report →The metabolic health score is 8.0/10, and Berberine needs careful framing. Berberine's strongest overall domain is dysregulated metabolism. Liu 2025 found improvements in triglycerides, fasting glucose, waist circumference, LDL-C, total cholesterol, BMI,…
Read the Berberine report →For metabolic health, Time-Restricted Eating earns 7.2/10 because the evidence points to a plausible use case without proving a universal response. Dai W et al. 2024 is the best anchor here because…
Read the Time-Restricted Eating report →Magnesium metabolic health earns 7.0/10 because Asbaghi 2022 anchors the most relevant signal. Magnesium fits metabolic health when low intake, stress load, mineral loss, or a form-specific target makes deficiency correction plausible.…
Read the Magnesium report →Molecular Hydrogen is a 7.0/10 metabolic health fit because LeBaron 2020 reports 60 participants over 24 weeks; reported improved lipids, glucose, HbA1c, inflammatory markers, and redox markers. Jamialahmadi 2024 points in the…
Read the Molecular Hydrogen report →The practical metabolic health read is 7.0/10 for Lactoferrin, with ELFIN Trial Investigators Group 2019 setting the ceiling. Metabolic-health score mainly reflects iron metabolism and low-hemoglobin states, not weight loss. Christofi 2024…
Read the Lactoferrin report →Metabolic health scores 7.0/10 because spirulina improves several risk factors at once. Huang 2018 pooled 12 trials and reported fasting glucose down 5.01 mg/dL, triglycerides down 39.2 mg/dL, and diastolic pressure down…
Read the Spirulina report →Metabolic health scores 7.0/10 on strong glycemic and time-efficiency evidence. Babraj 2009 improved insulin sensitivity by 23 percent in young men after two weeks of all-out sprints, with insulin area-under-curve down 37…
Read the Sprinting (Sprint Interval Training) report →The metabolic health use case earns 7.0/10 for Tesamorelin, anchored by Ellis et al. 2025. Tesamorelin reduces VAT and triglyceride-related risk markers, but glucose effects are mixed. Stanley 2012 found VAT responders…
Read the Tesamorelin report →Broader metabolic health lands at 6.8/10 because the glycemic, lipid, blood-pressure, and endothelial benefits cluster into a coherent cardiometabolic improvement rather than one isolated marker. The Crowe-White 2022 flavan-3-ol dietary guideline, built…
Read the Polyphenols (Dietary) report →The Norwegian 4x4 protocol receives a 6.5/10 score for metabolic-health, a rating supported by Tjonna 2008 showing superior improvements in VO2max and metabolic-syndrome markers versus continuous moderate exercise. The Norwegian 4x4 approach…
Read the Norwegian 4×4 report →Glycine metabolic health earns 6.5/10 because Soh 2024 anchors the most relevant signal. Glycine fits metabolic health because glycine participates in sleep signaling, glutathione, collagen, methylation, and nervous-system balance, depending on the…
Read the Glycine report →Metabolic health scores 6.5 because sustained moderate-intensity aerobic volume reliably improves glucose handling, lipids, and insulin sensitivity, and loaded walking delivers more of that stimulus per minute than walking alone. The supporting…
Read the Rucking (Weighted Walking) report →For metabolic health, Ketogenic Diet earns 6.5/10 because the evidence points to a plausible use case without proving a universal response. Eshaghhosseiny Z et al. 2024 is the best anchor here because…
Read the Ketogenic Diet report →NMN metabolic health earns 6.5/10 because Yoshino 2021 anchors the most relevant signal. NMN fits metabolic health when raising NAD+ is likely to matter for older, metabolically stressed, or performance-tracking users. The…
Read the NMN (Nicotinamide Mononucleotide) report →For metabolic-health, Methylene Blue lands at 6.5/10 because Ramsay 2007 supports the strongest part of the claim. The existing rationale points to this narrower claim: Mitochondrial ATP restoration supports the metabolic-health rationale,…
Read the Methylene Blue report →The evidence for SLU-PP-332 in the metabolic-health use case scores 6.5/10, reflecting preclinical data from mouse models of obesity and metabolic syndrome Billon 2024. ERR agonism by SLU-PP-332 shifts metabolism toward fatty-acid…
Read the SLU-PP-332 report →The metabolic-health case for Infrared Sauna is 6.3/10 because Hamaya 2025 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: Passive heating may improve some metabolic markers…
Read the Infrared Sauna report →For readers tracking metabolic health, Blood-Flow Restriction Training deserves 6.0/10 because Huang et al. 2025 gives the strongest anchor. Metabolic stress and muscle gain support metabolic health indirectly, with strongest relevance in…
Read the Blood-Flow Restriction Training report →Metabolic-health scores 6.0/10 because Sun 2025 found PBM improved waistline, weight, and BMI in obesity trials, though comparator heterogeneity limits confidence. This is an emerging use case rather than a core one.…
Read the Red Light Therapy report →Astaxanthin looks most relevant to metabolic health at 6.0/10 because Laurindo 2025 reports 8 randomized controlled studies; 312 randomized participants by included-study table; triglycerides and HDL-C improved; LDL-C and total cholesterol were…
Read the Astaxanthin report →Metabolic-health support earns Whole-Body Vibration a 6.0/10 because pooled diabetes data show modest but inconsistent glycemic improvements Fabregat-Fernandez 2024. Whole-Body Vibration has been examined in people with type 2 diabetes, where some…
Read the Whole-Body Vibration report →Mechanistically, Omega-3 scores 6.0/10 for metabolic health because the evidence points to a plausible use case without proving a universal response. Norouzzadeh et al. 2026 is the best anchor here because it…
Read the Omega-3 report →Metabolic health scores 6.0/10, carried by the insulin-resistance and mitochondrial data. Kumar 2023 reported a 64 percent fall in HOMA-IR plus reduced waist circumference, and the diabetes pilot Sekhar 2022 lowered insulin…
Read the GlyNAC (Glycine + N-Acetylcysteine) report →In metabolic health, Senolytics rates 6.0/10 because Baker et al. 2016 supports selective use. Senescent preadipocyte and adipose-inflammation mechanisms are plausible from preclinical D+Q work, but F+Q human metabolic endpoints are not…
Read the Senolytics report →Chlorella earns 6.0/10 for metabolic health because the same Fallah 2018 meta-analysis reported a small fasting-glucose reduction of 4.23 mg/dL (P=0.041) alongside the lipid and blood-pressure shifts, suggesting a broad, gentle metabolic…
Read the Chlorella report →For metabolic health, MOTS-c lands at 6.0/10 because context matters. Lee 2015 showed MOTS-c improved insulin sensitivity and diet-induced obesity measures in mice, while Zhou 2024 found circulating MOTS-c differs by metabolic…
Read the MOTS-c report →Metabolic health improves broadly, not just on the scale. Across the Phase 3 program orforglipron significantly improved blood pressure, lipids, and waist circumference versus placebo, per Wharton 2025, and it lowered the…
Read the Orforglipron (Foundayo) report →The metabolic health case for TRT (Testosterone Replacement Therapy) is 6.0/10 because Jones 2011 reports Corrected v0.x PMID; supports modest metabolic and sexual-function benefits in hypogonadal men with T2D or metabolic syndrome.…
Read the TRT (Testosterone Replacement Therapy) report →Metabolic health gains are strong because CagriSema attacks weight and glucose together. In REDEFINE 2, people with type 2 diabetes saw large improvements and 74% reached an HbA1c at or below 6.5%,…
Read the CagriSema (Cagrilintide + Semaglutide) report →Vitamin C lands at 5.5/10 for general metabolic health. The supporting evidence overlaps with its glycemic and lipid data: Ashor 2017 reported modest HbA1c, fasting glucose, triglyceride, and total cholesterol improvements that…
Read the Vitamin C (Ascorbic Acid) report →TUDCA scores 5.5/10 for metabolic health because Kars 2010 gives a small but direct human insulin-sensitivity signal. In obese adults, four weeks of TUDCA improved hepatic insulin sensitivity by 30 percent and…
Read the TUDCA (Tauroursodeoxycholic Acid) report →Exogenous ketones produce genuine acute metabolic effects. Myette-Cote 2018 found a ketone ester before an oral glucose load lowered glucose area-under-curve about 17 percent in 20 healthy adults. Stubbs 2018 showed a…
Read the Exogenous Ketones report →The metabolic-health case lands at 5.5/10 on the strength of one replicated lab line. Ham 2024 randomized 75 adults to 350 mg magnesium per day from deep-seawater extract for 12 weeks and…
Read the Quinton Marine Plasma (Seawater Minerals) report →Metabolic markers move broadly in the right direction. Across trials, triglycerides fell by roughly 27 to 37 percent, blood pressure dropped modestly, and serum uric acid declined substantially, per Ji 2023. The…
Read the Mazdutide (IBI362) report →Survodutide moves several metabolic levers at once. A 16-week head-to-head against semaglutide in type 2 diabetes showed comparable blood-sugar lowering plus more weight loss, per Bluher 2024. A post-hoc analysis found blood…
Read the Survodutide (BI 456906) report →Metabolic health is one of the better-supported sulforaphane indications. Axelsson 2017 reported broccoli sprout extract improved fasting glucose and HbA1c in 97 type 2 diabetes patients, with effects concentrated in the obese…
Read the Sulforaphane report →The practical metabolic-health read on Ca-AKG (Calcium Alpha-Ketoglutarate) is 5.4/10 because Filip 2007 anchors the strongest signal. The existing rationale points to this narrower claim: No direct human metabolic-health RCT. AKG's central…
Read the Ca-AKG (Calcium Alpha-Ketoglutarate) report →Metabolic health lands at 5.2/10, carried mostly by the precursor and liver-adjacent data rather than by glutathione monotherapy. Honda 2017 saw triglycerides and non-esterified fatty acids fall alongside ALT in fatty-liver patients,…
Read the Glutathione (GSH) report →For metabolic-health, Electrolytes lands at 5.0/10 because Cheuvront 2014 supports the strongest part of the claim. The existing rationale points to this narrower claim: Magnesium is a cofactor in hundreds of enzymatic…
Read the Electrolytes report →Vitamin D3 + K2 metabolic health earns 5.0/10 because Pittas 2019 anchors the most relevant signal. Vitamin D3 + K2 fits metabolic health when deficiency, bone risk, immune seasonality, or fat-soluble nutrient…
Read the Vitamin D3 + K2 report →Metabolic health scores 5.0/10. The cardiovascular and mortality cohort data implies a broad metabolic benefit, since the men who saunaed most also had lower blood pressure and inflammation, and heat stress activates…
Read the Traditional Sauna (Finnish Dry-Heat) report →Full-Body EMS belongs in the 5.0/10 range for metabolic health because the signal is conditional. Guretzki 2024 found a small favorable metabolic-syndrome score effect, but individual lipids, insulin markers, and inflammatory biomarkers…
Read the Full-Body EMS report →The metabolic story is mixed. A 2018 meta-analysis in Current Pharmaceutical Design found curcumin lowered fasting glucose, HOMA-IR, HbA1c, and triglycerides in metabolic syndrome, but showed no significant effect on LDL or…
Read the Curcumin report →The metabolic-health case for NR (Nicotinamide Riboside) is 5.0/10 because Martens 2018 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: NAD+ increase supports metabolic pathways, but…
Read the NR (Nicotinamide Riboside) report →Metabolic health scores moderately because amylin signaling improves several markers at once without forcing insulin secretion. Slowed gastric emptying and suppressed post-meal glucagon flatten glucose excursions, and the large weight loss in…
Read the Cagrilintide (AM833) report →Metabolic health looks promising on early data but rests on the same short window. In the VENTURE Phase 2 injectable trial, about 78 percent of prediabetic participants returned to normal glucose levels…
Read the VK2735 (Viking Therapeutics) report →Modest fat loss preserves lean mass: Astrup 1992 Metabolism showed 4.5 kg additional fat loss with 2.8 kg less FFM loss vs placebo over 8 weeks in 14 obese women on E+C…
Read the Ephedrine report →Vangipurapu 2019 found nine amino acids associated with decreased insulin secretion and elevated glucose over 7.4 years in Finnish men. Observational design prevents causality, but it justifies caution with chronic high-dose use.
Read the Essential Amino Acids report →Zhang 2025 pooled 25 RCTs and found improvements in several glycolipid and blood-pressure markers, but no significant changes for several insulin, lipid, BMI, or waist endpoints.
Read the Saffron report →Metabolic health sits at 4.5/10 as a composite of small lipid, glucose, and inflammatory signals rather than a strong dedicated effect. The most defensible metabolic angle is in statin users and people…
Read the Coenzyme Q10 (CoQ10 / Ubiquinol) report →The Arabi 2023 umbrella review of cardiometabolic meta-analyses found quercetin lowers SBP and insulin but does not affect DBP, lipids, inflammation, anthropometrics, FBG, or HOMA-IR consistently. Tamtaji 2019 in metabolic syndrome populations…
Read the Quercetin report →Metabolic health is mostly mechanistic; the strongest human data is the cardiovascular and mortality cohort rather than glycemic endpoints. Treat as unproven for blood sugar specifically.
Read the Ergothioneine report →One small human RCT lowered LDL-C and blood pressure but raised insulin resistance; the net metabolic picture is mixed and underpowered.
Read the Fucoidan (Brown Seaweed Polysaccharide) report →Metabolic-health evidence is inconsistent and population-dependent. Timmers 2011 showed calorie-restriction-like metabolic effects in obese humans, but Poulsen 2013 did not replicate meaningful benefit in obese men at high dose. Yoshino 2012 was…
Read the Resveratrol report →Preserved v0.x score. Metabolic claims are mostly mechanism and anecdote. Diabetic-foot-ulcer work such as Lima E Silva Filho 2024 is wound-care evidence in diabetic patients, not proof of glucose-control or insulin-sensitivity benefit.…
Read the Ozone Therapy report →Metabolic health improves mostly downstream of the weight loss rather than as a direct effect. In a respiration-chamber study the drug raised satiety, lifted nighttime energy expenditure about 4.6 percent, and increased…
Read the Tesofensine report →Mixed evidence: PEARL biomarkers were mostly neutral, while chronic exposure and labeling keep glucose and lipid risk high.
Read the Rapamycin report →Diabetic wound-care evidence is strong, and reviews suggest HBOT can affect glucose handling acutely. McIntosh 2021 documents intra-session glucose changes in patients with diabetes. This does not make hyperbaric oxygen therapy a…
Read the Hyperbaric Oxygen Therapy report →Gai 2025 reviews anti-aging and metabolic endpoints, but the human metabolic evidence is not strong enough to make this a primary use case.
Read the Spermidine report →Indirect metabolic support through oxidative-stress reduction and homocysteine lowering, but no large metabolic-outcome RCT base. Not a glucose or weight intervention.
Read the NAC (N-Acetylcysteine) report →Metabolic benefit is mostly secondary to stress reduction. Salve 2019 supports modest movement in stress-linked cardiometabolic measures, but there is no dedicated high-confidence metabolic RCT base. Additive glucose lowering with diabetes medications…
Read the Ashwagandha report →Robinson 2024 (Robinson 2024, n=30, 12 weeks, 200 mg/day) raised circulating C15:0 but did not show a reliable full-cohort improvement in fasting glucose, insulin, HOMA-IR, body weight, BMI, or hs-CRP. The updated…
Read the C15 (Pentadecanoic Acid) report →Metabolic claims are indirect through testosterone support in older men. No strong human glucose, insulin, or body-composition trial supports Tongkat Ali as a metabolic-health tool.
Read the Tongkat Ali report →The metabolic picture is weak where it matters. A 2018 crossover trial found oral butyrate improved insulin sensitivity only in lean subjects, with no effect in the metabolic syndrome group most likely…
Read the Sodium Butyrate report →Indirect via stress reduction, cortisol lowering, improved sleep.
Read the HRV Biofeedback report →Mineral content and fulvic-acid transport could support metabolic enzyme function, but human metabolic outcomes are not well-tested. Use this as indirect support, not a glucose or lipid intervention.
Read the Shilajit report →A preliminary Taiwan pilot suggested HbA1c movement in prediabetes, but the result is not enough for a strong metabolic-health claim. Weight, glucose, and insulin endpoints need larger peer-reviewed trials.
Read the Lion’s Mane report →Downstream mitochondrial signal only. Hodzic Kuerec 2024 found no clear anthropometric or broad metabolic outcome effect in humans.
Read the Urolithin A report →Hanssen 2015 Nature Medicine showed 10 days of cold acclimation (14-15 degC, 2-6h/day) raised peripheral insulin sensitivity by approximately 43 percent in n=8 type 2 diabetes patients via skeletal-muscle GLUT4 translocation. Van…
Read the Cold Plunge report →Composition reviews note antidiabetic activity in animal models, but no human metabolic trial exists; the effect is preclinical only.
Read the Pine Pollen report →Glucose tolerance normalized in obese mice, but mostly with related NNMT inhibitors such as JBSNF-000088 (Kannt 2018), not 5-Amino-1MQ itself.
Read the 5-Amino-1MQ report →No direct metabolic-health evidence. A TESTS 2025 subgroup signal by diabetes was exploratory and does not establish glucose, insulin, or weight benefits.
Read the Thymosin Alpha-1 report →Mitochondrial function underlies metabolic health, but direct human metabolic endpoint data are limited and no diabetes or insulin-sensitivity RCT drives this report.
Read the SS-31 (Elamipretide) report →Metabolic health is humanin's second-strongest mechanistic story, but it sits at a moderate score because the cleanest data came from rodents and a more potent analogue. Continuous central humanin infusion improved whole-body…
Read the Humanin report →Nothing matches those filters.
Head-to-head reports and category rankings that name a winner on this use case.
Tirzepatide, at 6.1, then semaglutide at 6.0, then orforglipron at 5.8 if you want the pill. All three are approved, all three have real trial evidence, and all…
Ca-AKG, urolithin A and MOTS-c tie at 6.5, and only the first two are things you can legally buy. SS-31 follows at 6.0. The bottom three score low…
Tesamorelin, at 6.2, and only if you have a clinical reason. Every one of the nine scores 6.2 or lower, so the category tops out at worth trying…
Shilajit at 7.4, phosphatidylserine at 7.3, tongkat ali at 7.0. TRT ranks seventh at 5.7 and wins nine of the eleven use cases outright. That inversion is the…
Neither, if fat loss is the goal. Both score 2.0 on body composition, which is the row a vendor sells them on. AOD-9604 scores 4.6 overall and its…
No. Berberine scores 6.8 and semaglutide 6.0, and that gap misleads almost everyone who reads it. Berberine scores higher because it is cheap, oral and easy to stop,…
No. Omega-3 scores 6.8 and C15:0 4.9, and the evidence gap is larger than the score gap. C15:0 has two small human trials. Omega-3 has outcome trials, prescription…
Tesamorelin, unless price is the only thing deciding. It is FDA-approved for visceral fat with Phase 3 trials behind it, while CJC-1295 is a gray-market research peptide whose…
CoQ10 scores 7.1 and methylene blue 6.1, yet methylene blue wins eleven of the seventeen shared use cases. The overall gap is risk, not effect. Methylene blue inhibits…
No, and the reason is mechanical. A drink raises blood ketones in an hour. It does not lower insulin, deplete glycogen or shift fuel use. The diet scores…
Start on sermorelin. Ipamorelin scores higher overall, yet sermorelin wins thirteen of the sixteen shared use cases and it is the one an anti-aging clinic actually prescribes. Ipamorelin…
Sulforaphane scores 6.8 and glutathione 6.2, and both have a delivery problem. Sulforaphane needs active myrosinase or you absorb half as much. Plain oral glutathione barely raises blood…
Semaglutide, at 9.0 out of 10 for metabolic health. For metabolic-health, Semaglutide reaches 9.0/10 because Moiz 2024 found about 12.1 percentage points greater weight loss than placebo in non-diabetic obesity trials.
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 6.5 out of 10 for metabolic health.
80 of the 126 interventions evaluated for metabolic health score 3.0 out of 10 or better, which is the cut-off for appearing on this page.
